Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase <scp>II</scp> study of dual phosphoinositol‐3‐kinase ( <scp>PI</scp> 3K) and mammalian target of rapamycin ( <scp>mTOR</scp> ) inhibitor <scp>BEZ</scp> 235 in patients with locally advanced or metastatic transitional cell carcinoma
PaperCitations, authors & open-access status
Phase <scp>II</scp> study of dual phosphoinositol‐3‐kinase ( <scp>PI</scp> 3K) and mammalian target of rapamycin ( <scp>mTOR</scp> ) inhibitor <scp>BEZ</scp> 235 in patients with locally advanced or metastatic transitional cell carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 60 citations, 2016 year and green oa status.
60
Citations
2016
Year
green
OA Status